KR102791470B1 - Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same - Google Patents
Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same Download PDFInfo
- Publication number
- KR102791470B1 KR102791470B1 KR1020210130570A KR20210130570A KR102791470B1 KR 102791470 B1 KR102791470 B1 KR 102791470B1 KR 1020210130570 A KR1020210130570 A KR 1020210130570A KR 20210130570 A KR20210130570 A KR 20210130570A KR 102791470 B1 KR102791470 B1 KR 102791470B1
- Authority
- KR
- South Korea
- Prior art keywords
- cabbage
- eif
- iso
- gene
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000723838 Turnip mosaic virus Species 0.000 title claims abstract description 31
- 101150095712 EIF(ISO)4E gene Proteins 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title description 25
- 238000009395 breeding Methods 0.000 title description 4
- 230000001488 breeding effect Effects 0.000 title description 4
- 238000010362 genome editing Methods 0.000 title description 3
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 title description 2
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 title description 2
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 title description 2
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 96
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 76
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 76
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 76
- 239000013604 expression vector Substances 0.000 claims abstract description 30
- 238000003259 recombinant expression Methods 0.000 claims description 17
- 108020005004 Guide RNA Proteins 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 108091033409 CRISPR Proteins 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 27
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000012937 correction Methods 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 description 50
- 230000009261 transgenic effect Effects 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 16
- 230000035772 mutation Effects 0.000 description 14
- 101710190212 Eukaryotic translation initiation factor isoform 4E Proteins 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 10
- 238000002944 PCR assay Methods 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 108020005091 Replication Origin Proteins 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 102100027304 Eukaryotic translation initiation factor 4E Human genes 0.000 description 6
- 101710091918 Eukaryotic translation initiation factor 4E Proteins 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 230000009885 systemic effect Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- 108700019146 Transgenes Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108091079001 CRISPR RNA Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000702421 Dependoparvovirus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000002241 Eukaryotic Initiation Factors Human genes 0.000 description 2
- 108010014863 Eukaryotic Initiation Factors Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000710078 Potyvirus Species 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 108091028113 Trans-activating crRNA Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 2
- 229960004261 cefotaxime Drugs 0.000 description 2
- 238000012350 deep sequencing Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241000724252 Cucumber mosaic virus Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000589601 Francisella Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
- 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
- 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
- 108010015268 Integration Host Factors Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
- 102100037935 Polyubiquitin-C Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 101150090155 R gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000500290 Ribgrass mosaic virus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 108010056354 Ubiquitin C Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000013602 bacteriophage vector Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000013601 cosmid vector Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000012247 phenotypical assay Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 108700026215 vpr Genes Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/06—Processes for producing mutations, e.g. treatment with chemicals or with radiation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/12—Processes for modifying agronomic input traits, e.g. crop yield
- A01H1/122—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- A01H1/1245—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance
- A01H1/126—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 eIF(iso)4E 유전자 교정에 의해 순무 모자이크 바이러스 저항성이 증가된 배추 식물체 및 이의 제조방법에 관한 것으로, 본 발명의 발현 벡터 및 이를 통해 유전자 교정된 배추 식물체는 유전자 교정기술을 이용하여 TuMV 저항성을 가진 것으로 이러한 변이체의 확보를 통해 배추 품종 개발 추진이 가능할 것으로 기대할 수 있다.The present invention relates to a cabbage plant having increased resistance to turnip mosaic virus by eIF(iso)4E gene correction and a method for producing the same. The expression vector of the present invention and the cabbage plant genetically corrected through the same have TuMV resistance using gene correction technology, and it is expected that the development of cabbage varieties will be promoted by securing such mutants.
Description
본 발명은 eIF(iso)4E 유전자 교정에 의해 순무 모자이크 바이러스 저항성이 증가된 배추 식물체 및 이의 제조방법에 관한 것이다.The present invention relates to a cabbage plant having increased resistance to turnip mosaic virus by eIF(iso)4E gene correction and a method for producing the same.
우리나라의 배추 생산액은 2006년 6,346억원으로 배추는 고추 다음으로 많이 재배되고 있는 4대 채소 중 하나이다. 배추는 주로 집약적 생산을 하기 때문에 여러 가지 병해충, 특히 바이러스에 아주 취약한 실정이다. 배추에 피해를 주는 바이러스로는 순무 모자이크 바이러스(Turnip mosaic virus), 오이 모자이크 바이러스(Cucumber mosaic virus), 그리고 질경이 모자이크 바이러스(Ribgrass mosaic virus) 등이 있으며, 특히 Potyvirus 속에 속하는 순무 모자이크 바이러스(Turnip mosaic virus)의 피해가 심각하다. 우리나라에서는 강원 고랭지 배추 농사 등의 수확량 손실을 초래하고 품질 저하로 상품성을 떨어뜨리는 주범 중의 하나이기도 하다.In Korea, cabbage production amounted to 634.6 billion won in 2006, making cabbage one of the four most cultivated vegetables after red pepper. Since cabbage is mainly produced intensively, it is very vulnerable to various pests and diseases, especially viruses. Viruses that damage cabbage include Turnip mosaic virus, Cucumber mosaic virus, and Ribgrass mosaic virus, and Turnip mosaic virus, which belongs to the Potyvirus genus, is particularly serious. In Korea, it is one of the main culprits that causes yield loss in cabbage farming in the Gangwon highlands and reduces marketability due to poor quality.
바이러스 병은 대부분 아직까지 마땅한 방제 방법이 없는 게 현실이고 농민들이 할 수 있는 최선의 방법은 깨끗한 종자나 모식물을 사용하고 물리적인 접촉이나 바이러스가 이용하는 곤충의 유입을 막는 것 정도이다. 그러나 바이러스를 방제하는 가장 확실한 방법은 저항성 품종을 사용하는 것이다.The reality is that there is still no proper control method for most viral diseases, and the best farmers can do is to use clean seeds or parent plants and prevent physical contact or the introduction of insects that the virus uses. However, the most certain way to control viruses is to use resistant varieties.
식물이 가진 바이러스 저항성에는 우성 저항성, 열성 저항성 및 비기주 저항성이 있는데, 이 중 열성 저항성에 대해서는 아직 연구가 미진하다. 열성 저항성은 숙주의 host factor를 이용한 저항성으로 R gene으로 결정되는 우성 저항성에 비해 보다 근본적으로 바이러스의 감염 기작을 차단하여 그 지속력이 길고 보다 다양한 바이러스에 저항성을 갖는 품종을 개발할 수 있는 장점이 있다.Plants have dominant resistance, recessive resistance, and non-host resistance as virus resistance, but research on recessive resistance is still insufficient. Recessive resistance is a resistance that utilizes the host factor of the host, and compared to dominant resistance determined by the R gene, it fundamentally blocks the virus infection mechanism, so it has the advantage of being able to develop varieties that are resistant to a longer period of time and a wider variety of viruses.
이미 많은 논문에서 배추과의 TuMV (순무 모자이크 바이러스) 감염성은 식물의 전사 개시 요소인 eIF4E와 eIF(iso)4E가 Potyvirus의 특징적인 단백질인 VPg (Virus genome linked protein)와 서로 상호 작용하여 결정된다고 보고되었다. 최근에는 배추과 eIF(iso)4E에서의 특정 아미노산 돌연변이가 TuMV VPg와의 상호작용을 파괴하여 바이러스의 열성 저항성을 유도할 수 있다는 것 또한 밝혀졌다. 바이러스 열성 저항성 기작을 조절하는 이러한 특정 아미노산들을 밝혀내면 미래에 보다 안정적이고 효율적인 저항성 배추의 선발 및 육종을 가능케 할 것이다.Many studies have already reported that the infectivity of TuMV (Turnip mosaic virus) in the cabbage family is determined by the interaction between the transcription initiation factors of the plant, eIF4E and eIF(iso)4E, and the characteristic protein of potyvirus, VPg (Virus genome linked protein). Recently, it has been found that specific amino acid mutations in the eIF(iso)4E of the cabbage family can induce the recessive resistance of the virus by destroying the interaction with TuMV VPg. Identifying these specific amino acids that regulate the virus recessive resistance mechanism will enable the selection and breeding of more stable and efficient resistant cabbages in the future.
본 발명의 일 목적은 배추 유래의 eIF(iso)4E 유전자에 혼성화 하는 gRNA를 암호화 하는 서열번호 1 내지 3 중 어느 하나 이상의 뉴클레오티드 서열; Cas9 단백질을 암호화 하는 뉴클레오티드 서열; 및 상기 뉴클레오티드 서열에 작동가능하게 연결된 프로모터를 포함하는 재조합 발현 벡터 을 제공하는 것이다.One object of the present invention is to provide a recombinant expression vector comprising at least one nucleotide sequence of SEQ ID NOs: 1 to 3 encoding a gRNA that hybridizes to an eIF(iso)4E gene derived from cabbage; a nucleotide sequence encoding a Cas9 protein; and a promoter operably linked to the nucleotide sequence.
본 발명의 다른 일 목적은 상기 재조합 발현 벡터가 도입된 배추로부터 자가수정을 통해 얻어진 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체를 제공하는 것이다.Another object of the present invention is to provide a genetically modified cabbage plant resistant to Turnip mosaic virus obtained through selfing from cabbage into which the recombinant expression vector has been introduced.
본 발명의 다른 일 목적은 발현 벡터를 배추의 하배축에 도입하는 단계; 상기 발현 벡터가 도입된 배추의 하배축을 배양하여 배추 형질전환 식물체 (T0)을 얻는 단계; 및 상기 배추 형질전환 식물체 (T0)의 자가수정을 통해 얻어진 후대 배추 유전자교정 식물체 (T1)인 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체를 얻는 단계; 를 포함하는 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체 제조방법을 제공하는 것이다. Another object of the present invention is to provide a method for producing a gene-edited cabbage plant resistant to Turnip mosaic virus, comprising the steps of: introducing an expression vector into the hypocotyl of cabbage; culturing the hypocotyl of cabbage into which the expression vector has been introduced to obtain a cabbage transformed plant ( T 0 ) ; and obtaining a gene-edited cabbage plant (T 1 ), which is a progeny cabbage gene-edited plant obtained through selfing of the cabbage transformed plant (T 0 ), and is resistant to Turnip mosaic virus.
본 발명의 일 양상은 배추 유래의 eIF(iso)4E 유전자에 혼성화 하는 gRNA를 암호화 하는 서열번호 1 내지 3 중 어느 하나 이상의 뉴클레오티드 서열; Cas9 단백질을 암호화 하는 뉴클레오티드 서열; 및 상기 뉴클레오티드 서열에 작동가능하게 연결된 프로모터를 포함하는 재조합 발현 벡터를 제공한다.One aspect of the present invention provides a recombinant expression vector comprising: at least one nucleotide sequence of SEQ ID NOs: 1 to 3 encoding a gRNA that hybridizes to an eIF(iso)4E gene derived from cabbage; a nucleotide sequence encoding a Cas9 protein; and a promoter operably linked to the nucleotide sequence.
본 명세서에서 상기 재조합 발현 벡터를 활용하여 배추 유래의 eIF(iso)4E 유전자를 돌연변이시키고 이를 통하여 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성을 가진 유전자 교정 배추 식물체를 생산하는 방법이 제공한다. In this specification, a method is provided for producing a genetically modified cabbage plant having resistance to Turnip mosaic virus by mutating the eIF(iso)4E gene derived from cabbage using the recombinant expression vector.
본 발명의 상기 '배추 유래의 eIF(iso)4E 유전자'는 eIF4E의 이소형을 나타내고, eIF(iso)4E는 eIF4E와 비슷한 기능을 나타낸다. 아라비돕시스 탈리아나의 eIF4E 및 eIF(iso)4E 단백질은 아미노산 수준에서 44% ~ 49% 동일한 것으로 알려져 있다.The 'cabbage-derived eIF(iso)4E gene' of the present invention represents an isoform of eIF4E, and eIF(iso)4E exhibits a function similar to eIF4E. It is known that eIF4E and eIF(iso)4E proteins of Arabidopsis thaliana are 44% to 49% identical at the amino acid level.
본 발명에서 사용되는 용어, "gRNA (가이드 RNA)"는 표적 DNA에 특이적인 RNA로, 가이드 RNA는 Cas9hc:NLS 과 복합체를 형성할 수 있다.The term "gRNA (guide RNA)" used in the present invention is RNA specific for target DNA, and the guide RNA can form a complex with Cas9hc:NLS.
상기 서열번호 1 내지 3의 gRNA중 어느 하나의 서열은 배추 유래의 eIF(iso)4E 유전자에 혼성화 하는 것으로, 혼성화 뒤 Cas9hc:NLS의 작용을 통해 gRNA는 배추 유래의 eIF(iso)4E 유전자를 암호화하는 DNA의 돌연변이를 유도한다. Any one of the gRNA sequences of the above sequence numbers 1 to 3 hybridizes to the eIF(iso)4E gene derived from cabbage, and after hybridization, through the action of Cas9hc:NLS, the gRNA induces a mutation in the DNA encoding the eIF(iso)4E gene derived from cabbage.
본 발명의 일 구체예에서 상기 발현 벡터는 gRNA를 암호화 하는 서열번호 1 내지 3를 포함하는 것일 수 있다. 상기 발현 벡터는 gRNA를 암호화 하는 서열번호 1 내지 3를 포함함으로써 배추 유래의 eIF(iso)4E 유전자를 돌연변이, 구체적으로 서열번호 4의 eIF(iso)4E 유전자 서열이 서열번호 5 내지 10 중 어느 하나로 돌연변이, 시켜 배추에 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성을 증가시킨다. In one specific embodiment of the present invention, the expression vector may include sequence numbers 1 to 3 encoding gRNA. The expression vector includes sequence numbers 1 to 3 encoding gRNA, thereby mutating the eIF(iso)4E gene derived from cabbage, specifically, mutating the eIF(iso)4E gene sequence of sequence number 4 to any one of sequence numbers 5 to 10, thereby increasing resistance to Turnip mosaic virus in cabbage.
본 발명에서 사용되는 용어, "Cas9 단백질"은 CRISPR/Cas9 시스템에서 필수적인 단백질 요소로써, CRISPR RNA(crRNA) 및 트랜스-활성화 crRNA(trans-activating crRNA: tracrRNA)로 불리는 두 RNA와 복합체를 형성하여, 활성 엔도뉴클레아제 또는 니카아제(nickase)로 작용할 수 있다. 상기 Cas9 단백질은 스타필로코커스(Staphylococcus) 속, 스트렙토코커스(Streptococcus) 속, 네이세리아 (Neisseria) 속, 파스테우렐라(Pasteurella) 속, 프란시셀라(Francisella) 속, 캄필로박터(Campylobacter) 속 유래인 것일 수 있으나 이에 한정되는 것은 아니며, 구체적인 일 예시로 상기 Cag9 단백질은 Cas9hc:NLS일 수 있다. The term "Cas9 protein" used in the present invention is an essential protein element in the CRISPR/Cas9 system, which can form a complex with two RNAs called CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA), and act as an active endonuclease or nickase. The Cas9 protein may be derived from the genus Staphylococcus , the genus Streptococcus , the genus Neisseria , the genus Pasteurella , the genus Francisella , and the genus Campylobacter , but is not limited thereto, and as a specific example, the Cag9 protein may be Cas9hc:NLS.
본 발명에서 사용되는 용어, "작동가능하게 연결된"은 유전자 발현 조절 서열과 다른 뉴클레오티드 서열사이의 기능적인 결합을 의미한다. 상기 유전자 발현 조절 서열은 복제원점(replication origin), 프로모터 및 전사 종결 서열(terminator) 등으로 이루어진 군으로부터 선택되는 1종 이상일 수 있다. 전사 종결 서열은 폴리아데닐화 서열(pA)일 수 있으며, 복제 원점은 f1 복제원점, SV40 복제원점, pMB1 복제원점, 아데노 복제원점, AAV 복제원점 또는 BBV 복제원점 등일 수 있으나, 이에 한정되는 것은 아니다.The term "operably linked" as used in the present invention means a functional linkage between a gene expression control sequence and another nucleotide sequence. The gene expression control sequence may be at least one selected from the group consisting of a replication origin, a promoter, and a transcription terminator. The transcription terminator sequence may be a polyadenylation sequence (pA), and the replication origin may be, but is not limited to, an f1 replication origin, an SV40 replication origin, a pMB1 replication origin, an adeno replication origin, an AAV replication origin, or a BBV replication origin.
본 발명에서 사용되는 용어, "프로모터"는 구조 유전자로부터의 DNA 업스트림의 영역을 의미하며, 전사를 개시하기 위하여 RNA 폴리머라아제가 결합하는 DNA 분자를 말한다.The term "promoter" as used in the present invention means a region of DNA upstream from a structural gene, and refers to a DNA molecule to which RNA polymerase binds to initiate transcription.
본 발명의 일 구체예에 따른 프로모터는 특정 유전자의 전사 개시를 조절하는 전사 조절 서열 중 하나로, 약 100bp 내지 약 2500bp 길이의 폴리뉴클레오티드 단편일 수 있다. 프로모터는 세포, 예를 들어, 진핵 세포(예컨대, 식물 세포, 또는 동물 세포(예를 들어, 인간, 마우스 등의 포유류 세포 등) 등)에서 전사 개시를 조절할 수 있으면, 제한 없이 사용 가능하다. 예를 들어, 프로모터는 CMV 프로모터(cytomegalovirus promoter(예를 들어, 인간 또는 마우스 CMV immediate-early 프로모터), U6 프로모터, EF1-alpha(elongation factor 1-a) 프로모터, EF1-alpha short(EFS) 프로모터, SV40 프로모터, 아데노바이러스 프로모터(major late promoter), pL λ 프로모터, trp 프로모터, lac 프로모터, tac 프로모터, T7 프로모터, 백시니아 바이러스 7.5K 프로모터, HSV의 tk 프로모터, SV40E1 프로모터, 호흡기 세포융합 바이러스(Respiratory syncytial virus; RSV) 프로모터, 메탈로티오닌 프로모터(metallothionin promoter), β-액틴 프로모터, 유비퀴틴 C 프로모터, 인간 IL-2(human interleukin-2) 유전자 프로모터, 인간 림포톡신(human lymphotoxin) 유전자 프로모터 및 인간 GM-CSF(human granulocyte-macrophage colony stimulating factor) 유전자 프로모터로 이루어진 군으로부터 선택되는 것일 수 있으나, 이에 한정되는 것은 아니다. A promoter according to one specific example of the present invention is one of the transcription regulatory sequences that regulates the initiation of transcription of a specific gene, and may be a polynucleotide fragment having a length of about 100 bp to about 2500 bp. The promoter may be used without limitation as long as it can regulate the initiation of transcription in a cell, for example, a eukaryotic cell (e.g., a plant cell, or an animal cell (e.g., a mammalian cell such as a human or a mouse, etc.)). For example, the promoter may be a cytomegalovirus promoter (e.g., human or mouse CMV immediate-early promoter), U6 promoter, EF1-alpha (elongation factor 1-a) promoter, EF1-alpha short (EFS) promoter, SV40 promoter, adenovirus promoter (major late promoter), pL λ promoter, trp promoter, lac promoter, tac promoter, T7 promoter, vaccinia virus 7.5K promoter, tk promoter of HSV, SV40E1 promoter, respiratory syncytial virus (RSV) promoter, metallothionin promoter, β-actin promoter, ubiquitin C promoter, human interleukin-2 gene promoter, human It may be selected from the group consisting of, but is not limited to, human lymphotoxin gene promoter and human granulocyte-macrophage colony stimulating factor (GM-CSF) gene promoter.
본 발명에서 사용되는 용어, "발현"은 폴리뉴클레오티드가 DNA 주형으로부터(예를 들어, mRNA 또는 기타 RNA 전사물로) 전사되는 과정 및/또는 이후에 전사된 mRNA가 펩티드, 폴리펩티드 또는 단백질로 번역되는 과정을 지칭한다. 폴리뉴클레오티드가 게놈 DNA로부터 유래된다면, 발현은 진핵 세포에서의 mRNA의 스플라이싱을 포함할 수 있다.The term "expression" as used herein refers to the process by which a polynucleotide is transcribed from a DNA template (e.g., into mRNA or other RNA transcripts) and/or the process by which the transcribed mRNA is subsequently translated into a peptide, polypeptide or protein. If the polynucleotide is derived from genomic DNA, expression can involve splicing of the mRNA in a eukaryotic cell.
본 발명의 일 구체예에 따른 재조합 발현 벡터는 플라스미드 벡터, 코즈미드 벡터 및 박테리오파아지 벡터, 아데노바이러스 벡터, 레트로바이러스 벡터 및 아데노-연관 바이러스 벡터와 같은 바이러스 벡터로 이루어진 군으로부터 선택되는 것일 수 있다. 재조합 발현 벡터로 사용될 수 있는 벡터는 당업계에서 사용되는 플라스미드(예를 들어, pcDNA 시리즈, pSC101, pGV1106, pACYC177, ColE1, pKT230, pME290, pBR322, pUC8/9, pUC6, pBD9, pHC79, pIJ61, pLAFR1, pHV14, pGEX 시리즈, pET 시리즈, pUC19 등), 파지(예를 들어, λgt4λB, λ-Charon, λΔz1, M13 등) 또는 바이러스 벡터(예를 들어, 아데노-연관 바이러스(AAV) 벡터 등) 등을 기본으로 하여 제작될 수 있으나, 이에 한정되는 것은 아니다.A recombinant expression vector according to one specific embodiment of the present invention may be selected from the group consisting of a plasmid vector, a cosmid vector, and a viral vector such as a bacteriophage vector, an adenovirus vector, a retrovirus vector, and an adeno-associated virus vector. Vectors that can be used as recombinant expression vectors can be produced based on, but are not limited to, plasmids used in the art (e.g., pcDNA series, pSC101, pGV1106, pACYC177, ColE1, pKT230, pME290, pBR322, pUC8/9, pUC6, pBD9, pHC79, pIJ61, pLAFR1, pHV14, pGEX series, pET series, pUC19, etc.), phage (e.g., λgt4λB, λ-Charon, λΔz1, M13, etc.) or viral vectors (e.g., adeno-associated virus (AAV) vectors, etc.).
본 발명에서 사용되는 용어, "재조합 발현 벡터"는 목적한 코딩 서열과, 특정 숙주 생물에서 작동가능하게 연결된 코딩 서열을 발현하는데 필수적인 적정 핵산 서열을 포함하는 재조합 DNA 분자를 의미한다. 진핵세포에서 이용 가능한 프로모터, 인핸서, 종결신호 및 폴리아데닐레이션 신호는 공지되어 있다.The term "recombinant expression vector" as used in the present invention means a recombinant DNA molecule comprising a desired coding sequence and appropriate nucleic acid sequences essential for expressing the coding sequence operably linked in a specific host organism. Promoters, enhancers, termination signals, and polyadenylation signals available in eukaryotic cells are known.
본 발명의 재조합 발현 벡터는 하나 이상의 선택성 마커를 더 포함할 수 있다. 상기 마커는 통상적으로 화학적인 방법으로 선택될 수 있는 특성을 갖는 핵산 서열로, 형질주입된 세포를 비형질주입 세포로부터 구별할 수 있는 모든 유전자가 이에 해당된다. 예를 들어, 글리포세이트(glyphosate), 글루포시네이트암모늄(glufosinate ammonium) 또는 포스피노트리신(phosphinothricin)과 같은 제초제 저항성 유전자, 암피실린(ampicillin), 카나마이신(kanamycin), G418, 블레오마이신(Bleomycin), 하이그로마이신(hygromycin), 클로람페니콜(chloramphenicol)과 같은 항생제 내성 유전자일 수 있으나, 이에 한정되는 것은 아니다.The recombinant expression vector of the present invention may further comprise one or more selectable markers. The markers are nucleic acid sequences having properties that can be selected, typically by chemical methods, and include any genes that can distinguish transfected cells from non-transfected cells. For example, the markers may be, but are not limited to, herbicide resistance genes such as glyphosate, glufosinate ammonium or phosphinothricin, antibiotic resistance genes such as ampicillin, kanamycin, G418, Bleomycin, hygromycin or chloramphenicol.
본 발명의 재조합 발현 벡터의 제작은 당해 기술 분야에서 잘 알려진 유전자 재조합 기술을 이용하여 제조할 수 있으며, 부위-특이적 DNA 절단 및 연결은 당해 기술 분야에서 일반적으로 알려진 효소 등을 사용하여 수행될 수 있다.The recombinant expression vector of the present invention can be produced using a genetic recombination technique well known in the art, and site-specific DNA cleavage and ligation can be performed using enzymes generally known in the art.
본 발명의 다른 일 양상은 상기 재조합 발현 벡터가 도입된 배추로부터 자가수정을 통해 얻어진 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체를 제공한다.Another aspect of the present invention provides a genetically modified cabbage plant resistant to Turnip mosaic virus obtained through selfing from cabbage into which the recombinant expression vector has been introduced.
상기 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체는 전술한 재조합 발현 벡터를 배추, 구체적으로 배추의 하배축, 에 도입한 뒤 얻은 배추 형질전환 식물체 (T0)를 자가수정을 통해 얻어진 후대 배추 유전자교정 식물체 (T1)인 것일 수 있다. The gene-edited cabbage plant resistant to the above Turnip mosaic virus may be a cabbage transgenic plant ( T0 ) obtained by introducing the above-described recombinant expression vector into cabbage, specifically, the hypocotyl of cabbage, and then a progeny cabbage gene-edited plant ( T1 ) obtained through selfing.
상기 발현 벡터를 배추의 하배축에 도입하는 방법은 공지의 방법을 통해 도입될 수 있고, 숙주 세포에 따라 적합한 표준 기술을 선택하여 수행할 수 있다. 이런 방법에는 예를 들어, 전기천공법(electroporation), 인산칼슘(CaPO4) 침전, 염화칼슘(CaCl2) 침전, 미세주입법(microinjection), 폴리에틸렌글리콜(PEG)법, DEAE-덱스트란법, 양이온성 리포좀법, 및 초산 리튬-DMSO법 등이 포함될 수 있으나, 이에 한정되는 것은 아니며, 구체적으로 미생물, 아그로박테리움 (균주 GV3101), 을 통해 상기 발현 벡터를 하배축에 도입할 수 있다. The method for introducing the above expression vector into the hypocotyl of cabbage can be introduced through a known method, and can be performed by selecting an appropriate standard technique depending on the host cell. Such methods may include, but are not limited to, electroporation, calcium phosphate (CaPO4) precipitation, calcium chloride (CaCl2) precipitation, microinjection, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method, and lithium acetate-DMSO method, and specifically, the expression vector can be introduced into the hypocotyl through a microorganism, Agrobacterium (strain GV3101).
상기 재조합 발현 벡터의 도입 및 발현을 통해 eIF(iso)4E 유전자의 돌연변이를 유도할 수 있고, 이를 통해 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성을 높일 수 있다. Through the introduction and expression of the above recombinant expression vector, a mutation in the eIF(iso)4E gene can be induced, thereby increasing resistance to Turnip mosaic virus.
본 발명의 일 구체예로 상기 배추 품종은 eIF(iso)4E 유전자의 돌연변이를 포함하는 것일 수 있으며, 구체적으로 서열번호 4의 eIF(iso)4E 유전자 서열이 서열번호 5 내지 9 중 어느 하나로 돌연변이 된 것일 수 있다.As a specific example of the present invention, the cabbage variety may include a mutation in the eIF(iso)4E gene, and specifically, the eIF(iso)4E gene sequence of SEQ ID NO: 4 may be mutated to any one of SEQ ID NOs: 5 to 9.
상기 재조합 발현 벡터가 도입된 배추는 공지의 배추를 이용할 수 있으나, 본 발명의 일 구체예로 상기 배추는 서울배추 (동원농산종묘) 일 수 있다. The cabbage into which the above recombinant expression vector has been introduced can be any known cabbage, but as a specific example of the present invention, the cabbage can be Seoul cabbage (Dongwon Agricultural Products).
본 발명의 다른 일 양상으로 상기 발현 벡터를 배추의 하배축에 도입하는 단계; 상기 발현 벡터가 도입된 배추의 하배축을 배양하여 배추 형질전환 식물체 (T0)을 얻는 단계; 및 상기 배추 형질전환 식물체 (T0)의 자가수정을 통해 얻어진 후대 배추 형질전환 식물체 (T1)인 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체를 얻는 단계; 를 포함하는 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체 제조방법을 제공한다.In another aspect of the present invention, a method for producing a gene-edited cabbage plant resistant to Turnip mosaic virus is provided, comprising the steps of: introducing the expression vector into the hypocotyl of cabbage; culturing the hypocotyl of cabbage into which the expression vector has been introduced to obtain a cabbage transformed plant (T 0 ); and obtaining a gene-edited cabbage plant resistant to Turnip mosaic virus, which is a progeny cabbage transformed plant (T 1 ) obtained through selfing of the cabbage transformed plant (T 0 ).
상기 하배축에 도입하는 단계는 전술한 발현 벡터를 배추의 하배축에 도입하는 단계로, 도입을 위한 방법을 전술한 바와 같다.The step of introducing into the hypocotyl of the above-mentioned plant is a step of introducing the above-mentioned expression vector into the hypocotyl of the cabbage, and the method for introduction is as described above.
상기 하배축은 발아하고 있는 어린식물에서 뿌리와 떡잎 사이에 있는 부분을 의미하며, 하배축을 적절한 배양조건에서 배양할 경우 싹이 형성될 수 있다. The hypocotyl refers to the part between the root and cotyledon in a germinating young plant, and when the hypocotyl is cultured under appropriate culture conditions, a sprout can be formed.
상기 배추 형질전환 식물체 (T0)을 얻는 단계는 상기 발현 벡터가 도입된 배추의 하배축을 배양하여 얻는 단계로서, 본 발명에서의 구체적인 방법으로, 발현 벡터를 포함하는 균주와 함께 배추의 하배축을 암배양한 뒤 명배양하여 배추 형질전환 식물체 (T0)를 얻을 수 있다. The step of obtaining the above-mentioned cabbage transformed plant (T 0 ) is a step of culturing the hypocotyl of the cabbage into which the expression vector has been introduced, and as a specific method in the present invention, the cabbage transformed plant (T 0 ) can be obtained by culturing the hypocotyl of the cabbage in the dark together with a strain containing the expression vector and then culturing it in the light.
상기 순무 모자이크 바이러스(Turnip mosaic virus)에 저항성인 유전자 교정 배추 식물체를 얻는 단계는 상기 배추 형질전환 식물체 (T0)의 자가수정을 통해 후대 배추 유전자교정 식물체 (T1)를 얻음으로 이룰 수 있다. 상기 자가수정 방법은 공지의 방법을 사용할 수 있다. The step of obtaining a gene-edited cabbage plant resistant to the above Turnip mosaic virus can be accomplished by obtaining a progeny gene-edited cabbage plant (T 1 ) through selfing of the above cabbage transformed plant (T 0 ). The selfing method can use a known method.
본 발명의 발현 벡터 및 이를 통해 유전자 교정된 배추 품종은 유전자 교정기술을 이용하여 TuMV 저항성을 가진 것으로 이러한 변이체의 확보를 통해 배추 품종 개발 추진이 가능할 것으로 기대할 수 있다.The expression vector of the present invention and the cabbage variety genetically corrected using the same are expected to enable the development of cabbage varieties by securing such mutants having TuMV resistance using genetic correction technology.
도 1은 배추의 형질전환 과정을 나타낸 도면이다.
도 2는 pECO101_eIF(iso)4E_gRNA1,2,3 vector 모식도를 나타낸 것이다.
도 3은 TumV 접종방법을 나타낸 도이다.
도 4는 배추 형질전환 식물체를 나타낸 도이다.
도 5는 배추 형질전환 식물체 transgene 검정을 위한 PCR 분석 결과를 나타낸 것이다.
도 6은 목표 유전자좌 내 변이를 확인한 결과를 나타낸 것이다.
도 7은 서울배추 6 T1 line PCR 검정 결과를 나타낸 것이다.
도 8은 서울배추 7 T1 line PCR 검정 결과를 나타낸 것이다.
도 9는 서울배추 6, 7 T1 line direct sequencing 분석 결과를 나타낸 도면이다.
도 10은 서울배추 T1 식물체 TuMV 저항성 ELISA 분석결과를 나타낸 것이다.Figure 1 is a diagram showing the transformation process of cabbage.
Figure 2 shows a schematic diagram of the pECO101_eIF(iso)4E_gRNA1,2,3 vector.
Figure 3 is a diagram showing the TumV inoculation method.
Figure 4 is a diagram showing a transformed cabbage plant.
Figure 5 shows the results of PCR analysis for transgene testing of cabbage transgenic plants.
Figure 6 shows the results of confirming mutations within the target locus.
Figure 7 shows the results of the Seoul cabbage 6 T 1 line PCR assay.
Figure 8 shows the results of the Seoul cabbage 7 T 1 line PCR assay.
Figure 9 is a diagram showing the results of direct sequencing analysis of Seoul cabbage 6, 7 T 1 line.
Figure 10 shows the results of ELISA analysis of Seoul cabbage T1 plants for TuMV resistance.
이하 하나 이상의 구체예를 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 하나 이상의 구체예를 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Below, one or more specific examples are described in more detail by way of examples. However, these examples are provided for illustrative purposes only and the scope of the present invention is not limited to these examples.
실험예 1: 실험재료 및 방법Experimental Example 1: Experimental Materials and Methods
실험예 1-1. 실험 재료Experimental Example 1-1. Experimental Materials
형질전환용 배추(서울배추, 동원농산종묘) 약 3,500립을 준비하였고, Transgene으로 pECO101_eIF(iso)4E_gRNA1,2,3 vector를 준비하였다 (도 2). 그리고, PCR 검정을 위한 primer를 표 1과 같이 준비하였다. 형질전환의 재료 1/2 Murashige & Skoog 선발 및 재분화 배지, Hygromycine, 유전자 도입을 위한 아그로박테리움 (균주 GV3101)을 준비하였다. About 3,500 cabbages (Seoul cabbage, Dongwon Agricultural Seed) for transformation were prepared, and the pECO101_eIF(iso)4E_gRNA1,2,3 vector was prepared as the transgene (Fig. 2). In addition, primers for PCR assay were prepared as shown in Table 1. Materials for transformation 1/2 Murashige & Skoog selection and redifferentiation medium, Hygromycine, and Agrobacterium (strain GV3101) for gene introduction were prepared.
specific primerTransgene
specific primer
실험예 1-2. 형질전환 과정Experimental Example 1-2. Transformation Process
표 4와 같은 조성으로 배지를 준비하였다.A medium was prepared with the composition shown in Table 4.
(4 mg/ml)BA
(4 mg/ml)
(1 mg/ml)NAA
(1 mg/ml)
(4 mg/ml)AgNO3
(4 mg/ml)
(250 mg/ml)Cefotaxime
(250 mg/ml)
(50 mg/ml)Hygromycin
(50 mg/ml)
종자 소독 및 파종을 위하여, 종자를 70% 에탄올 용액에 1분 침지시킨다음 sdw로 2-3회 세척하였다. 그리고 25% 락스 용액에 20분간 소독하였고 (shaking), sdw로 5-6회 세척한 뒤 sdw가 있는채로 1시간가량 방치시켰다. 1/2MS, 2% 수크로오스, 0.5% plant agar 배지에 파종하였다. 25℃에서 3일간 암배양 상태에서 배양시켰다. 접종된 절천체 채위 및 pre-culture를 위하여 발아된 유식물체를 명배양으로 옮겨 3-4시간 빛을 받게 하였다 (경화과정). 그리고 배축의 엽록소가 안보이는 부위를 0.7-1cm 길이로 잘라서 pre-culture 배지 (MS+BA 4.0mg/L+NAA 1.0mg/mL)에 가로로 치상시킨 뒤 23℃에서 암배양 2일 시켰다. 균주 배양의 접종 및 선발을 위하여, 접종 예정일 전날에 균주를 배양 (OD:0.6-0.8)하여 준비하였다. 접종당일에 4000rpm, 20분간 원심분리하여 얻어진 균주를 MS (MS+글루코오스 36g/L, pH5.2)로 희석시킨 후 1시간동안 shaking 하였다 (23℃). Pre-culture한 하배축을 균주와 접종 (10분)한 후 23℃에서 2일간 암배양하였다. 선발배지에 이직하여 명배양 (SI: MS+BA 4.0mg/L, AgNO3 4.0m/L, cefotaxime 250mg/L, hygromacin 4.0mg/L) 시킨 후 2-3주 간격으로 상태를 관찰하면서 배지를 교체하였다. 완전한 형태의 싹이 형성되면 rooting 배지로 이식하였다 (MS+수크로오스 20g/L) (도 1).For seed disinfection and sowing, seeds were soaked in a 70% ethanol solution for 1 minute and then washed 2-3 times with SDW. Then, they were disinfected in a 25% bleach solution for 20 minutes (shaking), washed 5-6 times with SDW, and left for about 1 hour with SDW. They were sown on a 1/2MS, 2% sucrose, and 0.5% plant agar medium. They were cultured in the dark at 25℃ for 3 days. For the selection of inoculated cutting bodies and pre-culture, the germinated plantlets were transferred to the light culture and exposed to light for 3-4 hours (hardening process). Then, the part of the hypocotyl where chlorophyll is not visible was cut into 0.7-1 cm long, planted horizontally on the pre-culture medium (MS+BA 4.0 mg/L+NAA 1.0 mg/mL), and then cultured in the dark at 23℃ for 2 days. For inoculation and selection of strain culture, strains were cultured (OD: 0.6-0.8) the day before the scheduled inoculation date. On the day of inoculation, the strains obtained by centrifugation at 4000 rpm for 20 minutes were diluted with MS (MS + glucose 36 g / L, pH 5.2) and shaken for 1 hour (23 ° C). Pre-cultured hypocotyls were inoculated with the strain (10 minutes) and then cultured in the dark at 23 ° C for 2 days. After transferring to the selection medium and performing light culture (SI: MS + BA 4.0 mg / L, AgNO3 4.0 m / L, cefotaxime 250 mg / L, hygromacin 4.0 mg / L), the medium was replaced while observing the condition at intervals of 2-3 weeks. When complete sprouts were formed, they were transplanted to the rooting medium (MS + sucrose 20 g / L) (Fig. 1).
실험예 1-3. TuMV 접종 방법Experimental Example 1-3. TuMV inoculation method
접종할 건전 식물체를 준비하고, Carborundum을 접종할 잎에 뿌려둔다. 그리고 준비된 바이러스원을 건전식물체에 접종하고, 접종이 끝난 잎은 물로 세척한 뒤 병징을 관찰하였다 (도 3).Prepare healthy plants to be inoculated, and spray Carborundum on the leaves to be inoculated. Then, inoculate the prepared virus source onto the healthy plants, and wash the leaves after inoculation with water and observe the symptoms (Fig. 3).
실험예 2: 실험 결과Experimental Example 2: Experimental Results
실험예 2-1. 배추 형질전환 식물체의 획득Experimental Example 2-1. Obtaining Transgenic Cabbage Plants
Hygromycin 4mg/ml 항생제 배지를 이용해 배추 형질전환 식물체를 선발하였다 (도 4). 그 결과 53개의 형질전환 식물체를 획득하였다. Cabbage transgenic plants were selected using hygromycin 4 mg/ml antibiotic medium (Fig. 4). As a result, 53 transgenic plants were obtained.
실험예 2-2. 배추 T0 형질전환 식물체 목표 유전자 삽입 여부 확인 Experimental Example 2-2. Confirmation of target gene insertion in cabbage T 0 transgenic plants
획득한 형질전환 식물체에 대해 PCR 검정을 수행하였다. gRNA 표적 위치를 포함하는 프라이머를 제작 (표 1)하여 PCR 검정을 수행하였으며, Takare exTaq (Takara Shuzo Co., Ltd., Shiga, Japan)을 이용하였다. 배추 형질전환 식물체 PCR 검정 결과 53개체 중 33개체에서 목표 유전자 삽입을 확인하였다 (도 5).PCR assay was performed on the obtained transgenic plants. Primers containing the gRNA target site were prepared (Table 1) and PCR assay was performed using Takare exTaq (Takara Shuzo Co., Ltd., Shiga, Japan). As a result of PCR assay on cabbage transgenic plants, insertion of the target gene was confirmed in 33 out of 53 plants (Fig. 5).
실험예 2-3. 배추 T0 형질전환 식물체 목표 유전자좌 내 변이 확인Experimental Example 2-3. Confirmation of mutation in target locus of cabbage T 0 transgenic plant
유전자 삽입 유무를 확인한 T0 형질전환 식물체를 목표 유전자좌 내 변이를 확인하기 위해 deep-sequencing을 수행하였다. 그 결과 목표 유전자좌 내의 In/Del을 확인하였으며, 큰 deletion된 형질전환 식물체도 확인하였다 (도 6). 목표 유전자좌 내 변이를 확인한 형질전환 식물체는 T0 형질전환 식물의 자가수정을 통해 T1 후대 종자를 획득하였다. 10개의 T1 line 중 3개의 서울배추 6, 7 T1 line에 대해서 PCR 분석을 실시하였다.The T 0 transgenic plants with confirmed gene insertion were subjected to deep sequencing to identify mutations within the target locus. As a result, In/Del within the target locus were identified, and transgenic plants with large deletions were also identified (Fig. 6). Transgenic plants with confirmed mutations within the target locus were used to obtain T 1 progeny seeds through selfing of the T 0 transgenic plants. PCR analysis was performed on three of the ten T 1 lines, Seoul cabbage 6 and 7 T 1 lines.
실험예 2-4. 배추 T1 유전자 교정 식물체 목표 유전자 삽입 여부 확인Experimental Example 2-4. Confirmation of insertion of target gene in cabbage T1 gene-edited plant
서울배추 6 T1 line의 경우 총 46개체 중 26개체에서 eIF(iso)4E 표적 유전자가 삽입된 것을 확인하였다 (도 7). 서울배추 7 T1 line의 경우 총 49개체 중 6개체에서 eIF(iso)4E 표적 유전자가 삽입된 것을 확인하였다 (도 8).In the case of the Seoul cabbage 6 T 1 line, it was confirmed that the eIF (iso) 4E target gene was inserted in 26 out of a total of 46 individuals (Fig. 7). In the case of the Seoul cabbage 7 T 1 line, it was confirmed that the eIF (iso) 4E target gene was inserted in 6 out of a total of 49 individuals (Fig. 8).
실험예 2-5. 배추 T1 형질전환 식물체 목표 유전자좌 내 변이 확인Experimental Example 2-5. Confirmation of mutation in target locus of transgenic cabbage T1 plants
목표 유전자 삽입이 확인된 개체 중 생육상태가 불량한 개체를 제외한 T1 식물체에 대해서 direct sequencing 분석을 실시하였다. 그 결과 서울배추 6 T1 line의 경우 총 26개체 중 19개체에서 목표 유전자좌 내 변이가 발생한 것을 확인하였고, 서울배추 7 T1 line의 경우 총 5개체 중 5개체 모두에서 목표 유전자좌 내 변이가 발생한 것을 확인하였다. 특히 7-44개체의 경우 large InDel을 확인하였다 (도 9).Direct sequencing analysis was performed on T 1 plants, excluding those with poor growth status among those in which the target gene insertion was confirmed. As a result, in the case of the Seoul cabbage 6 T 1 line, it was confirmed that mutations occurred in the target locus in 19 out of 26 plants, and in the case of the Seoul cabbage 7 T 1 line, it was confirmed that mutations occurred in all 5 out of 5 plants in the target locus. In particular, a large InDel was confirmed in the case of the 7-44 plant (Fig. 9).
실험예 2-6. 배추 T1 형질전환 식물체 바이러스 저항성 검정Experimental Example 2-6. Virus resistance test of transgenic cabbage T1 plants
TuMV 접종 2주 후, 배추 6, 7 line T1 형질전환 식물체를 육안 관찰하여 표현형을 조사하였다. 병 평가는 총 4단계로 분류하였으며, 다음과 같이 분류하였다(0, immune with no detectable symptom; R, Resistance, infection limited to inoculated leaves but no systemic infection; +, susceptibility, systemic mosaic infection; +N, susceptibility, systemic infection with necrosis). 저항성(0 또는 R), 이병성(N 또는 +N)은 추후 ELISA 분석 결과와 비교하였다. 그리고 ELISA 결과 1보다 낮은 수치는 저항성(Resistance, R), 1보다 높은 수치는 이병성(Susceptible, S)로 분류하였다. Two weeks after TuMV inoculation, the phenotypes of the transgenic plants of cabbage lines 6 and 7 T 1 were examined by visual observation. The disease evaluation was classified into four stages as follows (0, immune with no detectable symptom; R, Resistance, infection limited to inoculated leaves but no systemic infection; +, susceptibility, systemic mosaic infection; +N, susceptibility, systemic infection with necrosis). Resistance (0 or R) and susceptibility (N or +N) were compared with the results of ELISA analysis. In addition, a value lower than 1 in the ELISA result was classified as resistance (R), and a value higher than 1 was classified as susceptible (S).
그리고 형질전환 식물체 6, 7 T1 line에 대한 TuMV 표현형 및 ELISA 결과를 비교하였다. 그 결과 6-19, 6-41, 6-42, 6-46, 7-44, 7-49 식물체가 표현형 및 ELISA 결과 모두 저항성을 보였다 (표 5, 6) (도 10). And the TuMV phenotypic and ELISA results for transgenic plant lines 6 and 7 T1 were compared. As a result, plants 6-19, 6-41, 6-42, 6-46, 7-44, and 7-49 showed resistance in both phenotypic and ELISA results (Tables 5 and 6) (Fig. 10) .
Z0, Immune with no detectable symptom (증상없음); R, resistance, infection limited to inoculated leaves but no systemic infection(접종부위에 제한적으로 감염되었지만 증상없음, 과민반응(HR)); +, susceptibility, systemic mosaic infection (모자이크 현상); +N, susceptibility, systemic infection with necrosis (괴사) Z 0, Immune with no detectable symptom (no symptoms); R, resistance, infection limited to inoculated leaves but no systemic infection (limited infection at the site of inoculation but no symptoms, hypersensitivity (HR)); +, susceptibility, systemic mosaic infection (mosaic phenomenon); +N, susceptibility, systemic infection with necrosis (necrosis)
* PC : POTY positive control, NC : POTY negative control* PC: POTY positive control, NC: POTY negative control
실험예 2-7. TuMV 저항성 배추 확인Experimental Example 2-7. Confirmation of TuMV-resistant cabbage
육안 표현형 검정 및 ELISA 결과 TuMV에 저항성을 보인 6개체의 direct sequencing을 확인하였다. 그 결과 6개체 모두 크고 작은 InDel을 확인할 수 있었다. Direct sequencing of six isolates that showed resistance to TuMV based on visual phenotypic assay and ELISA results was performed. As a result, large and small InDels were confirmed in all six isolates.
상기한 결과들을 요약하면 다음과 같다:The above results can be summarized as follows:
본 연구의 target 유전자로 진핵생물번역개시인자 4E (eIF4E)의 isomer인 eIF(iso)4E 유전자를 동시에 targeting할 수 있는 sgRNA를 선정하였으며, pECO101를 이용하여 플라스미드 벡터를 제작하였다. In this study, we selected an sgRNA that can simultaneously target the eIF(iso)4E gene, an isomer of eukaryotic translation initiation factor 4E (eIF4E), as the target gene, and constructed a plasmid vector using pECO101.
제작된 플라스미드 벡터는 식물체에 형질전환하기 위해 아그로박테리움(GV3101)에 transformation하였으며, 이를 이용하여 형절전환을 수행하였다.The constructed plasmid vector was transformed into Agrobacterium (GV3101) for plant transformation, and transformation was performed using this.
배추 종자 약 3,500립을 파종하여 10,000개 이상의 하배축을 확보하였으며, 이를 아그로박테리움(GV3101)과 공동배양하여 Agro-transformation을 진행하였으며, hygromycin을 선발 및 재분화로 pECO101_eIF(iso)4E_gRNA1,2,3에 대한 배추 형질전환체를 확보하였다. Approximately 3,500 cabbage seeds were sown, and more than 10,000 hypocotyls were obtained. These were co-cultured with Agrobacterium (GV3101) to perform Agrotransformation. Cabbage transformants for pECO101_eIF(iso)4E_gRNA1,2,3 were obtained through hygromycin selection and redifferentiation.
Transgene 유전자의 단편 염기서열(primer)를 이용해 PCR 검정을 실시하여 형질전환 유전자 삽입 유무를 확인하였으며, 유전자 삽입이 확인된 식물체에 대해서 목표 유전자좌 내 변이를 확인하기 위해 deep-sequencing 분석을 실시하였다. The presence or absence of transgenic gene insertion was confirmed by performing a PCR assay using a fragment base sequence (primer) of the transgene gene, and deep-sequencing analysis was performed on plants in which gene insertion was confirmed to confirm mutations within the target locus.
목표 유전자좌 내 변이가 발생한 배추 형질전환 식물체는 세대진전을 거쳐 T1 식물체를 획득하였다. Transgenic cabbage plants with mutations in the target locus were passed through generations to obtain T1 plants.
T1 세대는 목표 유전자 삽입 여부를 확인하기 위해 PCR 검정을 수행하였으며, 목표 유전자가 삽입이 확인된 식물체는 목표 유전자좌 내에 변이를 확인하기 위해 direct-sequencing 분석을 실시하였다. The T1 generation was subjected to PCR assay to confirm whether the target gene was inserted, and plants in which the target gene was confirmed to have been inserted were subjected to direct-sequencing analysis to confirm mutations within the target locus.
또한 PCR 검정을 통해 목표 유전자가 삽입된 개체를 TuMV 접종하여 육안판별 및 ELISA 분석을 실시하였다.Additionally, individuals with the target gene inserted through PCR assay were inoculated with TuMV, and visual identification and ELISA analysis were performed.
최종적으로 개발된 TuMV 저항성 배추는 유전자 교정기술을 기반으로 한 육종소재로 사용될 수 있음을 확인하였다. Finally, it was confirmed that the developed TuMV-resistant cabbage can be used as a breeding material based on gene editing technology.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to preferred embodiments thereof. Those skilled in the art will appreciate that the present invention may be implemented in modified forms without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered from an illustrative rather than a restrictive perspective. The scope of the present invention is indicated by the claims, not the foregoing description, and all differences within the scope equivalent thereto should be interpreted as being included in the present invention.
<110> REPUBLIC OF KOREA(RURAL DEVELOPMENT ADMINISTRATION) <120> Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same <130> RDA-BPN210024 <160> 10 <170> KoPatentIn 3.0 <210> 1 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> gRNA1 <400> 1 ccccaggcgg cggcgccttg tttgg 25 <210> 2 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> gRNA2 <400> 2 cactcaggat cttcccactt agg 23 <210> 3 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> gRNA3 <400> 3 gaacgaagcc cttgcggcgg cgg 23 <210> 4 <211> 210 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E WT sequence <400> 4 agaagtcttg gacggtgtcg aaggtatagg ctttgcgaag ggaggctccc caggcggcgc 60 cttgctttgt ttggattggt tatcgaacca gaaactccac tttctttcga gcttgtcagc 120 aggctgcttc tccgtctctc tgttgccggt acttccgccg ccgcaagggc ttcgttcaca 180 tcctctgtcg ccatcgcact cgatggtcaa 210 <210> 5 <211> 188 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-19 sequence <400> 5 ggttggcatg cgagggaggc tcccaggcgg cgccttgctt tggtttggat tggttatcga 60 accagaaact ccactttctt tcgagcttgt cagcaggctg cttctccgtc gtctctgttg 120 ccggtacttc cgccgcccgc aagggcttcg ttcacatcct ctgtcgccat cgcactcgat 180 cggtcaaa 188 <210> 6 <211> 185 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-41 sequence <400> 6 ggatgctgcg aggaggctcc caggcggcgc cttgctttgg tttggattgg ttatcgaacc 60 agaaactcca ctttctttcg agcttgtcag caggctgctt ctccgtcgtc tctgttgccg 120 gtacttccgc cgcccgcaag ggcttcgttc acatcctctg tcgccatcgc actcgatcgg 180 tcaaa 185 <210> 7 <211> 187 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-42 sequence <400> 7 gtggtgctgc gaggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgcccgcaa gggcttcgtt cacttcctct gtcgccatcg cactcgatcg 180 ttcaaaa 187 <210> 8 <211> 189 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-46 sequence <400> 8 atgtatgctg cgagggaggc tcccaggcgg cgccttgctt tggtttggat tggttatcga 60 accagaaact ccactttctt tcgagcttgt cagcaggctg cttctccgtc gtctctgttg 120 ccggtacttc cgccgcccgc aggggcttct ttcacttcct cggtcccctt cccattcaat 180 cggccaaaa 189 <210> 9 <211> 186 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 7-44 sequence <400> 9 ttatccttac gaggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgccggggc ggctttcaca tcctccgtcg ccatcatcct ccatcagtca 180 aaaaaa 186 <210> 10 <211> 187 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 7-49 sequence <400> 10 ggagcttgcg agggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgaccgcaa gggcttcgtt cacatcctct gtcgccatcg cactcgatcg 180 gtcaaaa 187 <110> REPUBLIC OF KOREA(RURAL DEVELOPMENT ADMINISTRATION) <120> Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same <130>RDA-BPN210024 <160> 10 <170> KoPatentIn 3.0 <210> 1 <211> 25 <212> DNA <213> Artificial Sequence <220> <223>gRNA1 <400> 1 ccccaggcgg cggcgccttg tttgg 25 <210> 2 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> gRNA2 <400> 2 cactcaggat cttcccactt agg 23 <210> 3 <211> 23 <212> DNA <213> Artificial Sequence <220> <223>gRNA3 <400> 3 gaacgaagcc cttgcggcgg cgg 23 <210> 4 <211> 210 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E WT sequence <400> 4 agaagtcttg gacggtgtcg aaggtatagg ctttgcgaag ggaggctccc caggcggcgc 60 cttgctttgt ttggattggt tatcgaacca gaaactccac tttctttcga gcttgtcagc 120 aggctgcttc tccgtctctc tgttgccggt acttccgccg ccgcaagggc ttcgttcaca 180 tcctctgtcg ccatcgcact cgatggtcaa 210 <210> 5 <211> 188 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-19 sequence <400> 5 ggttggcatg cgagggaggc tcccaggcgg cgccttgctt tggtttggat tggttatcga 60 accagaaact ccactttctt tcgagcttgt cagcaggctg cttctccgtc gtctctgttg 120 ccggtacttc cgccgcccgc aagggcttcg ttcacatcct ctgtcgccat cgcactcgat 180 cggtcaaa 188 <210> 6 <211> 185 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-41 sequence <400> 6 ggatgctgcg aggaggctcc caggcggcgc cttgctttgg tttggattgg ttatcgaacc 60 agaaactcca ctttctttcg agcttgtcag caggctgctt ctccgtcgtc tctgttgccg 120 gtacttccgc cgcccgcaag ggcttcgttc acatcctctg tcgccatcgc actcgatcgg 180 tcaaa 185 <210> 7 <211> 187 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-42 sequence <400> 7 gtggtgctgc gaggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgccccgcaa gggcttcgtt cacttcctct gtcgccatcg cactcgatcg 180 ttcaaaa 187 <210> 8 <211> 189 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 6-46 sequence <400> 8 atgtatgctg cgagggaggc tcccaggcgg cgccttgctt tggtttggat tggttatcga 60 accagaaact ccactttctt tcgagcttgt cagcaggctg cttctccgtc gtctctgttg 120 ccggtacttc cgccgcccgc aggggcttct ttcacttcct cggtcccctt cccattcaat 180 cggccaaaa 189 <210> 9 <211> 186 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 7-44 sequence <400> 9 ttatccttac gaggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgccggggc ggctttcaca tcctccgtcg ccatcatcct ccatcagtca 180 aaaaaa 186 <210> 10 <211> 187 <212> DNA <213> Artificial Sequence <220> <223> eIF(iso)4E 7-49 sequence <400> 10 ggagcttgcg agggaggctc ccaggcggcg ccttgctttg gtttggattg gttatcgaac 60 cagaaactcc actttctttc gagcttgtca gcaggctgct tctccgtcgt ctctgttgcc 120 ggtacttccg ccgaccgcaa gggcttcgtt cacatcctct gtcgccatcg cactcgatcg 180 gtcaaaa 187
Claims (6)
상기 재조합 발현 벡터는 배추 유래의 eIF(iso)4E 유전자에 혼성화하는 gRNA를 암호화 하는 서열번호 1 내지 3 중 어느 하나 이상의 뉴클레오티드 서열;
Cas9 단백질을 암호화 하는 뉴클레오티드 서열; 및
상기 뉴클레오티드 서열에 작동가능하게 연결된 프로모터를 포함하는 재조합 발현 벡터이고,
상기 유전자 교정 배추 식물체는 서열번호 4의 eIF(iso)4E 유전자의 서열이 서열번호 6 내지 9 중 어느 하나로 돌연변이 된 유전자 교정 배추 식물체.
A genetically modified cabbage plant resistant to Turnip mosaic virus obtained through selfing from a cabbage into which a recombinant expression vector has been introduced,
The above recombinant expression vector comprises at least one nucleotide sequence selected from SEQ ID NOS: 1 to 3 encoding a gRNA that hybridizes to the eIF(iso)4E gene derived from cabbage;
A nucleotide sequence encoding the Cas9 protein; and
A recombinant expression vector comprising a promoter operably linked to the above nucleotide sequence,
The above genetically corrected cabbage plant is a genetically corrected cabbage plant in which the sequence of the eIF(iso)4E gene of sequence number 4 is mutated to any one of sequence numbers 6 to 9.
상기 재조합 발현 벡터가 도입된 배추는 서울배추인 유전자 교정 배추 식물체.
In the third paragraph,
The cabbage into which the above recombinant expression vector has been introduced is a genetically modified cabbage plant called Seoul cabbage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210130570A KR102791470B1 (en) | 2021-10-01 | 2021-10-01 | Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210130570A KR102791470B1 (en) | 2021-10-01 | 2021-10-01 | Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20230047566A KR20230047566A (en) | 2023-04-10 |
| KR102791470B1 true KR102791470B1 (en) | 2025-04-08 |
Family
ID=85984538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210130570A Active KR102791470B1 (en) | 2021-10-01 | 2021-10-01 | Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102791470B1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070055889A (en) | 2005-11-28 | 2007-05-31 | 주식회사 바이오브리딩연구소 | Chinese cabbage virus disease (TuMV-C4) disease resistance associated SCARR marker |
| GB201010740D0 (en) * | 2010-06-25 | 2010-08-11 | Univ Warwick | A plant |
-
2021
- 2021-10-01 KR KR1020210130570A patent/KR102791470B1/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 비특허문헌1(박사학위논문)* |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230047566A (en) | 2023-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110494039B (en) | Method for modifying resistance spectrum of spinach to downy mildew | |
| US5187073A (en) | Process for transforming gramineae and the products thereof | |
| AU2020282488B2 (en) | Parthenogenetic haploid induction gene DMP and application thereof | |
| KR20210039306A (en) | Gene editing method using transgenic plants expressing CRISPR/Cas9 and gRNA, respectively | |
| CN112522259A (en) | Method for cultivating plant type improved rice material with Oslg1 mutant phenotype through haploid mediation | |
| CN118879661B (en) | Rice EPSPS enzyme mutant, expression cassette, recombinant bacterium or application thereof | |
| CN116376934A (en) | Utilization of NLR Gene on Pm55/SuPm55 and Its Resistance to Wheat Powdery Mildew | |
| CN112812162B (en) | A kind of rice resistance-related gene and its application | |
| KR102791470B1 (en) | Chinese cabbage varieties resistant to Turnip mosaic virus by eIF(iso)4E gene editing and Method for breeding of the same | |
| CN117660476A (en) | Rice tillering related coding gene and application thereof | |
| CN113462661B (en) | SIZ1 protein separated from corn, encoding gene thereof and application thereof in variety improvement | |
| CN110402814A (en) | Breeding method of a tomato recessive nuclear male sterile line | |
| WO2023129099A1 (en) | Developing orobanche (orobanche spp., phelipanche spp.) resistance in tomato (solanum lycopersicum), using gene editing technology (crispr) | |
| CN111875689B (en) | Method for creating male sterile line by using tomato green stem close linkage marker | |
| CN113416747B (en) | Method for creating temperature-sensitive male sterile plant | |
| CN113817033A (en) | Application of ZmELF3.1 protein and functional deletion mutant thereof in regulating and controlling number or layer number of aerial roots of crops | |
| KR102722360B1 (en) | Method for Producing Genome-edited Brassica rapa Plant Having Immortalization and the Plant Thereof | |
| CN119662679B (en) | Method for improving citrus canker resistance by CsSERK gene | |
| CN118745439B (en) | Method and application of CsERF1 gene to improve resistance to citrus canker | |
| CN109929017A (en) | Plant leaf width GAP-associated protein GAP KRDP1 and its encoding gene and application | |
| CN117305326B (en) | Broccoli BoCENH3 gene and its application in haploid induction | |
| CN114656540B (en) | Application of protein CYCA3-1 in improving saline-alkali resistance of corn | |
| CN119351430B (en) | CsACS6 gene and application thereof in improving citrus canker resistance | |
| CN114656543B (en) | Application of protein ATNDX and DNA molecule encoding protein ATNDX in regulation and control of salt and alkali tolerance of plants | |
| CN112813045B (en) | Cotton GhALS Mutant Protein, Gene and Its Molecular Marker and Application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20211001 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20240715 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20250318 |
|
| GRNT | Written decision to grant | ||
| PR0702 | Registration of establishment of national patent |
Patent event code: PR07021E01D Comment text: Registration of Establishment of National Patent Patent event date: 20250401 |
|
| PR1002 | Payment of registration fee |
Payment date: 20250401 End annual number: 20 Start annual number: 1 |
|
| PG1601 | Publication of registration |